본문 바로가기
KERD
논문KCI 등재

자궁내막세포에 노출된 프탈레이트의 독성연구

Analysis of Toxicity in Endometrial Cells Exposed Phthalate

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

프탈레이트(2-ethylhexyl phthalate, DEHP)는 환경오염물질 중 하나이며 플라스틱 가소제로 사용된다. 자궁내막증(endometriosis)은 병인이 잘 알려지지 않는 복잡한 질환으로estrogen 유사 작용을 하는 DEHP 노출과 연관성이 있을 것으로 추측하고 있다. 이에 본 연구는 DEHP를 Ishikawa cell에 노출시켜 Ishikawa cell에 미치는 잠재적 독성을 조사하여 자궁내막증의 병인 연관성을 알아보고자 하였다. 실험은 DEHP 농도(0, 0.01, 0.1, 1, 5 μM)를 단계적으로 처리하여 시간별(24, 48, 72 h)로 노출하였고 이에 따른 세포의 생존율, 염증 반응 그리고 ECM 분해 단백질과의 관계를 살펴본 결과 5 μM DEHP 농도에서 48, 72 h 노출하였을 때 세포 생존율와 염증성 사이토카인 TNF-α 그리고 ECM 분해 단백질 MMP-9의 발현이 시간 의존적으로 증가함을 확인하였다. 이러한 결과는 일정 농도 이상에서의 estrogen 유사 물질인 DEHP 노출이 Ishikawa cell에노출 시간에 의존하여 독성으로 작용하면서 세포 생존율 증가와 염증에 영향을 주어 자궁내막증의 병인에 잠재적인 역할을할 수 있음을 암시한다. 향후 자궁내막증의 발병 기전에 내분비교란 물질이 미치는 영향을 연구하여 자궁내막증 예방을 위한전략을 제시할 것이다.

Abstract

Di-ethylhexyl phthalate (DEHP) is an environmental contaminant that is used as a plasticizer. Endometriosis is a complex disease with an unknown etiology that is believed to be associated with exposure to DEHP. The present study examined the potential toxicity of DEHP by exposing endometrial adenocarcinoma cells (Ishikawa cells) to DEHP. In the experiments, the cells were treated with stepwise DEHP concentrations (0, 0.01, 0.1, 1, and 5 μM) for different exposure times (24, 48, and 72 h). When the relationship between the resulting survival rate of the cells and initial inflammation was examined, the cell viability, expression of TNF-α, an inflammatory mediator, and the expression of MMP-9, an ECM degradation protein, were increased remarkably when the cells were exposed to 5 μM DEHP for 48 and 72 hours. These results suggest that the exposure of Ishikawa cells to certain concentrations of DEHP, estrogen mimics, may cause time-dependent toxicity that affects the cell viability and inflammation, implying a potential role in the etiology of endometriosis. Further research on the effects of endocrine disruptors on the pathogenesis of endometriosis may reveal strategies to prevent this disease.

참고문헌 (40)

  1. Shaco-Levy R, "Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium", Eur J Obstet Gynecol Reprod Biol, 139, pp.226~232 (2008)
  2. State of the art assessment of endocrine disruptors. Final Report, "Kortenkamp A", European Commission, ~ (2011)
  3. Diamanti-Kandarakis E, "Endocrine-disrupting chemicals : an endocrine society scientific statement", Endocr Rev, 30, pp.293~342 (2009)
  4. Halden RU, "Plastics and health risks", Annu Rev Public Health, 31, pp.179~194 (2010)[DOI]
  5. "Fourth national report on human exposure to environmental chemicals" (2012)[URL]
  6. Maryam ZJ, "Effect of sunlight exposure on phthalates migration from plastic containers to packaged juices", J Environ Health Sci Eng, 16, pp.292~ (2018)[DOI]
  7. Xia X, "Levels, distribution, and health risk of phthalate esters in urban soils of Beijing, China", J Environ Qual, 40, pp.1643~1651 (2011)
  8. Zolfaghari M, "Occurrence, fate and effects of Di(2-ethylhexyl)phthalate in wastewater treatment plants : a review", Environ Pollut, 194, pp.281~293 (2014)
  9. Rier S, "Environmental dioxins and endometriosis", Toxicol Sci, 70, pp.161~170 (2002)
  10. Cobellis L, "High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis", Hum Reprod, 18, pp.1512~1515 (2003)
  11. 박호, "후코이단이 혈관 내피세포의 신생혈관 생성 효과 및 관련 유전자의 발현에 미치는 영향", 대한임상검사과학회지, 49(4), pp.323~328 (2017), 대한임상검사과학회[DOI]
  12. Rosen EM, "Tumor necrosis factor stimulates epithelial tumor cell motility", Cancer Res, 51, pp.5315~5321 (1991)
  13. Egeblad M, "New functions for the matrix metalloproteinases in cancer progression", Nat Rev Cancer, 2, pp.161~174 (2002)
  14. Ramos-DeSimone N, "Activation of matrix metalloproteinase-9(MMP-9)via a converging plasmin", stromelysin-1 cascade enhances tumor cell invasion, 1999, pp.274, 13066~13076
  15. Parks WC, "Matrix metalloproteinases as modulators of inflammation and innate immunity", Nat Rev Immunol, 4, pp.617~629 (2004)
  16. Durmaz E, "Plasma phthalate levels in pubertal gynecomastia", Pediatrics, 125, pp.122~129 (2010)
  17. Chen FP, "Lower concentrations of phthalates induce proliferation inhuman breast cancer cells", Climacteric, 17, pp.377~384 (2014)
  18. Zhu H, "Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells", Oncol Rep, 23, pp.129~139 (2010)
  19. Chen X, "Activation of the PI3K-Akt-mTor signaling pathway promotes DEHP-induced Hep3b cell proliferation", Food Chem Toxicol, 59, pp.325~333 (2013)
  20. Jepsen KF, "Monophthalates promote IL-6 and IL-8 production in the human epithelial cell line A549", Toxicol In Vitro, 18, pp.265~269 (2004)[DOI]
  21. Kim YH, "Increased viability of endometrial cells by in vitro treatment with di-(2-ethylhexyl)phthalate", Fertil Steril, 94, pp.2413~2416 (2010)
  22. Wei N, "Long-term di(2-ethylhexyl)-phthalate exposure promotes proliferation and survival of HepG2 cells via activation of NFB", Toxicol In Vitro, 42, pp.86~92 (2017)
  23. Vaskivuo TE, "Apoptosis and apoptosis‐ related factors Bcl‐2, Bax, tumor necrosis factor‐, and NF‐ B in human endometrial hyperplasia and carcinoma", Cancer, 95, pp.1463~1471 (2002)
  24. Ungefroren H, "Interaction of tumor cells with the microenvironment", Cell Commun Signal, 9, pp.1~8 (2011)
  25. Qian BZ, "Macrophage diversity enhances tumor progression and metastasis", Cell, 141, pp.39~51 (2010)
  26. Bølling AK, "Mono-2-ethylhexylphthalate (MEHP) induces TNF- release and macrophage differentiation through different signaling pathways in RAW264.7 cells", Toxicol Lett, 209, pp.43~50 (2012)
  27. Lebovic DI, "Immunobiology of endometriosis", Fertil Steril, 75, pp.1~10 (2001)
  28. Weiss G, "Inflammation in reproductive disorders", Reprod Sci, 16, pp.216~229 (2009)
  29. Ulukus M, "Immunology of endometriosis", Minerva Ginecol, 573, pp.237~248 (2005)
  30. Harada T, "Role of cytokines in endometriosis", Fertil Steril, 76, pp.1~10 (2001)
  31. Iwabe T, "Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression", J Clin Endocrinol Metab, 85, pp.824~829 (2000)
  32. Eisermann J, "Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery", Fertil Steril, 50, pp.573~579 (1988)
  33. Peng Y, "Activation of the CXCL16", CXCR6 Axis by TNF-a contributes to ectopic endometrial stromal cells migration and invasion, 2018, pp.1, 1~8
  34. Van den Steen PE, "Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9(MMP-9)", Crit Rev Biochem Mol Biol, 37, pp.375~536 (2002)
  35. Eisen NH, "General immunology" (1980), JB Lippincot
  36. Rodgers WH, "Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones", J Clin Invest, 94, pp.946~953 (1994)
  37. Jones JL, "Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas", J Pathol, 189, pp.161~168 (1999)
  38. Wu CY, "Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution", Clin Cancer Res, 13, pp.2054~2060 (2007)
  39. Leibovich SJ, "Macrophage-induced angiogenesis is mediated by tumor necrosis factor-a", Nature, 329, pp.630~632 (1987)
  40. Zhang X, "Enhanced expressions of matrix metalloproteinase(MMP)-2 and-9 and vascular endothelial growth factors(VEGF)and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding", Fertil Steril, 93, pp.2362~2367 (2010)

관련 논문AI추천

이 간행물의 다른 논문 (14건)